Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 9.02 USD 2.73% Market Closed
Market Cap: 955.1m USD

Intrinsic Value

RCUS's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one RCUS stock under the Base Case scenario is 15.68 USD. Compared to the current market price of 9.02 USD, Arcus Biosciences Inc is Undervalued by 42%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RCUS Intrinsic Value
15.68 USD
Undervaluation 42%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Arcus Biosciences Inc

Valuation History Unavailable

Historical valuation for RCUS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Arcus Biosciences Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Arcus Biosciences Inc

Current Assets 1B
Cash & Short-Term Investments 978m
Receivables 25m
Other Current Assets 13m
Non-Current Assets 134m
Long-Term Investments 14m
PP&E 112m
Other Non-Current Assets 8m
Efficiency

Free Cash Flow Analysis
Arcus Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Arcus Biosciences Inc

Revenue
258m USD
Operating Expenses
-568m USD
Operating Income
-310m USD
Other Expenses
27m USD
Net Income
-283m USD
Fundamental Scores

RCUS Profitability Score
Profitability Due Diligence

Arcus Biosciences Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

Exceptional 1-Year Revenue Growth
Negative Revenue Growth Forecast
Declining ROE
Declining ROIC
15/100
Profitability
Score

Arcus Biosciences Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

RCUS Solvency Score
Solvency Due Diligence

Arcus Biosciences Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
50/100
Solvency
Score

Arcus Biosciences Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RCUS Price Targets Summary
Arcus Biosciences Inc

Wall Street analysts forecast RCUS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCUS is 30.97 USD with a low forecast of 14.14 USD and a high forecast of 48.3 USD.

Lowest
Price Target
14.14 USD
57% Upside
Average
Price Target
30.97 USD
243% Upside
Highest
Price Target
48.3 USD
435% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Arcus Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RCUS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

RCUS Insider Trading
Buy and sell transactions by insiders

RCUS News

What is the Intrinsic Value of one RCUS stock?

The intrinsic value of one RCUS stock under the Base Case scenario is 15.68 USD.

Is RCUS stock undervalued or overvalued?

Compared to the current market price of 9.02 USD, Arcus Biosciences Inc is Undervalued by 42%.

Back to Top